
7 Companies Racing to Make Sickle Cell Cures Accessible
Since the world's first gene-edited therapy for sickle cell disease won approval, scientists are tackling an urgent new challenge: making these cures simpler, safer, and available to everyone who needs them. Seven innovative companies are leading the charge to transform a $2.2 million treatment into something far more practical.
